Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from
Gehan Fatima1, Akm Ashiquzzaman1, Sang Seong Kim1
1Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Rep. of Korea.
Insights
Alzheimer's disease involves vascular aging, impaired brain fluid clearance, and inflammation. New machine learning tools help analyze data to understand these connections for better diagnostics and treatments.
Area of Science:
- Neuroscience
- Vascular Biology
- Biomedical Engineering
Background:
- Alzheimer's disease (AD) pathogenesis involves intricate links between cerebrovascular dysfunction, impaired glymphatic system function, and neuroinflammation.
- Vascular aging, marked by arterial stiffness and reduced cerebral blood flow (CBF), compromises the pulsatile forces essential for glymphatic clearance, leading to amyloid-beta (Aβ) buildup and cognitive decline.
Purpose of the Study:
- To review the mechanistic interplay between vascular aging, glymphatic impairment, and neuroinflammation in Alzheimer's disease.
- To explore the potential of machine learning (ML) tools in analyzing multimodal data for enhanced diagnostic precision in AD.
Main Methods:
- Literature review synthesizing current research on the interconnectedness of vascular, glymphatic, and inflammatory systems in AD.
- Exploration of machine learning applications, specifically DeepLabCut and Motion sequencing (MoSeq), for analyzing complex biological data.
Main Results:
- Vascular aging significantly disrupts glymphatic clearance, promoting Aβ accumulation and cognitive deficits.
- Machine learning tools show promise in integrating imaging and behavioral data to elucidate vascular-glymphatic dysfunction.
Conclusions:
- Understanding the crosstalk between vascular dysfunction, glymphatic impairment, and neuroinflammation is crucial for AD pathogenesis.
- Integrating advanced ML techniques with multimodal analyses offers a pathway to improved early diagnostics and targeted interventions for neurovascular health in AD.
Abstract:
Alzheimer's disease (AD) is driven by complex interactions between vascular dysfunction, glymphatic system impairment, and neuroinflammation. Vascular aging, characterized by arterial stiffness and reduced cerebral blood flow (CBF), disrupts the pulsatile forces necessary for glymphatic clearance, exacerbating amyloid-beta (Aβ) accumulation and cognitive decline. This review synthesizes insights into the mechanistic crosstalk between these systems and explores their contributions to AD pathogenesis. Emerging machine learning (ML) tools, such as DeepLabCut and Motion sequencing (MoSeq), offer innovative solutions for analyzing multimodal data and enhancing diagnostic precision. Integrating ML with imaging and behavioral analyses bridges gaps in understanding vascular-glymphatic dysfunction. Future research must prioritize these interactions to develop early diagnostics and targeted interventions, advancing our understanding of neurovascular health in AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood


